$2.66 0.4%
Price vs. AI Score (Last 150 days)
Data gathered: December 9

Data Bits

Data Bits Value / Change Benchmark
Job Posts 31 -3.1%
Sentiment 70 0%
Webpage traffic 22,000 -24.9%
Employee Rating 72 0%
Google Adspend $1,125 N/A N/A
Google Trends 30 -41.2%
Linkedin Employees 1,121 N/A
Patents 125 0%
4chan Mentions 0%
Facebook Engagement 90 34.3%
Facebook followers 15,332 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 2,148 0%
Twitter Followers 3,730 -0.1% N/A
Youtube Subscribers 2,780 0%
Instagram Followers 837 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 59 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region.

Price $2.66
Target Price Sign up
Market Cap $257M
Dividend Yield 0.101
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23104M64M39M-3M4.1M
Q2 '23118M81M38M-2.6M-460,000
Q1 '23118M79M39M600,0002.3M
Q4 '22115M72M43M-1.9M2.7M
Q3 '2296M62M35M-5.4M-2.2M

Insider Transactions

Hoge Michael filed to sell 402,199 shares at $2.5.
December 4 '23
Chew Jesse filed to sell 381,920 shares at $2.5.
December 4 '23
Chalke Sandeep filed to sell 555,640 shares at $2.5.
December 4 '23
Pervaiz Ali filed to sell 404,859 shares at $2.5.
December 4 '23
Winter Suzanne C filed to sell 1,369,811 shares at $2.5.
December 4 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.